Drug Profile
GLPG 0187
Alternative Names: GLPG-0187; IRAMLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator ProStrakan
- Developer Galapagos NV
- Class Antineoplastics; Small molecules
- Mechanism of Action Integrin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer metastases
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Cancer-metastases in Netherlands (IV, Infusion)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Cancer-metastases(In volunteers) in Belgium (PO, Capsule)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Cancer-metastases(In volunteers) in Belgium (PO, Liquid)